First Quadrant’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,847
| Closed | -$2.36M | – | 185 |
|
|
2021
Q4 | $2.36M | Hold |
9,847
| – | – | 0.25% | 85 |
|
|
2021
Q3 | $2.79M | Hold |
9,847
| – | – | 0.33% | 64 |
|
|
2021
Q2 | $3.41M | Sell |
9,847
-1,735
| -15% | -$526K | 0.39% | 50 |
|
|
2021
Q1 | $3.24M | Sell |
11,582
-80
| -0.7% | -$21.6K | 0.34% | 54 |
|
|
2020
Q4 | $2.86M | Sell |
11,662
-48
| -0.4% | -$12.4K | 0.29% | 62 |
|
|
2020
Q3 | $3.32M | Sell |
11,710
-331
| -3% | -$92.3K | 0.42% | 44 |
|
|
2020
Q2 | $3.22M | Sell |
12,041
-10,737
| -47% | -$3.23M | 0.43% | 45 |
|
|
2020
Q1 | $7.21M | Sell |
22,778
-9,800
| -30% | -$2.97M | 1.05% | 11 |
|
|
2019
Q4 | $9.67M | Sell |
32,578
-13,262
| -29% | -$3.68M | 0.81% | 19 |
|
|
2019
Q3 | $10.7M | Buy |
45,840
+3,646
| +9% | +$849K | 1% | 12 |
|
|
2019
Q2 | $9.87M | Buy |
42,194
+7,131
| +20% | +$1.65M | 0.69% | 22 |
|
|
2019
Q1 | $8.29M | Buy |
35,063
+4,372
| +14% | +$1.38M | 0.64% | 29 |
|
|
2018
Q4 | $9.24M | Sell |
30,691
-77,279
| -72% | -$24.7M | 0.74% | 24 |
|
|
2018
Q3 | $38.1M | Sell |
107,970
-41,563
| -28% | -$14.3M | 0.85% | 10 |
|
|
2018
Q2 | $43.4M | Buy |
149,533
+78,799
| +111% | +$22.2M | 0.81% | 11 |
|
|
2018
Q1 | $19.4M | Sell |
70,734
-25,964
| -27% | -$8.06M | 0.37% | 98 |
|
|
2017
Q4 | $30.8M | Sell |
96,698
-12,661
| -12% | -$4.06M | 0.58% | 31 |
|
|
2017
Q3 | $34.2M | Sell |
109,359
-47,111
| -30% | -$14M | 0.66% | 18 |
|
|
2017
Q2 | $42.5M | Buy |
156,470
+40,534
| +35% | +$10.7M | 0.85% | 14 |
|
|
2017
Q1 | $31.7M | Buy |
115,936
+75,001
| +183% | +$21.2M | 0.62% | 22 |
|
|
2016
Q4 | $11.6M | Sell |
40,935
-6,149
| -13% | -$1.82M | 0.24% | 151 |
|
|
2016
Q3 | $14.7M | Sell |
47,084
-1,351
| -3% | -$400K | 0.31% | 111 |
|
|
2016
Q2 | $11.7M | Hold |
48,435
| – | – | 0.26% | 135 |
|
|
2016
Q1 | $12.6M | Sell |
48,435
-36,874
| -43% | -$9.74M | 0.27% | 121 |
|
|
2015
Q4 | $26.1M | Sell |
85,309
-5,068
| -6% | -$1.46M | 0.57% | 48 |
|
|
2015
Q3 | $26.4M | Hold |
90,377
| – | – | 0.59% | 45 |
|
|
2015
Q2 | $36.5M | Sell |
90,377
-16
| -0% | -$6.42K | 0.77% | 26 |
|
|
2015
Q1 | $38.2M | Sell |
90,393
-5,214
| -5% | -$2.06M | 0.79% | 30 |
|
|
2014
Q4 | $32.5M | Sell |
95,607
-29,938
| -24% | -$9.69M | 0.68% | 41 |
|
|
2014
Q3 | $41.5M | Buy |
125,545
+67,500
| +116% | +$22.3M | 0.93% | 20 |
|
|
2014
Q2 | $18.3M | Sell |
58,045
-92,400
| -61% | -$27.8M | 0.41% | 72 |
|
|
2014
Q1 | $46M | Buy |
150,445
+69,985
| +87% | +$22.2M | 1.04% | 16 |
|
|
2013
Q4 | $22.5M | Sell |
80,460
-12,850
| -14% | -$3.32M | 0.53% | 54 |
|
|
2013
Q3 | $22.5M | Sell |
93,310
-1,920
| -2% | -$430K | 0.57% | 48 |
|
|
2013
Q2 | $20.5M | Buy |
+95,230
| New | +$20.3M | 0.55% | 53 |
|
Other funds holding BIIB
First Quadrant's BIIB Position: Q1 2022 in Review
First Quadrant sold out of Biogen (BIIB) in Q1 2022, closing a stake of 9,847 shares — an estimated $2.36M sold.
First Quadrant first reported a position in BIIB in Q2 2013 and held it in 35 quarters. The position peaked at $46M in Q1 2014. 953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.
- First Quadrant reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 9,847 Biogen shares in Q1 2022, an estimated $2.36M.
- First Quadrant first reported a position in Biogen in Q2 2013 and held it in 35 quarters.
- First Quadrant's Biogen position peaked at $46M in Q1 2014.
- 953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.